Senior insider sale
President and CEO at ADMA BIOLOGICS, INC. — senior position signals high conviction
$4.11M
251K shares
GROSSMAN ADAM S plans to sell 251K shares of ADMA BIOLOGICS, INC. valued at approximately $4.11M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Stock Option Exercise - Options Granted February 26, 2024
Cash
Stock Option Exercise - Options Granted March 06, 2023
Cash
Restricted Stock Units vesting - granted March 7, 2025
Compensatory payment
Restricted Stock Units vesting - granted March 6, 2025
Compensatory payment
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/17/2026 | Stock Option Exercise - Options Granted February 26, 2024 Cash | 60K | — |
2/17/2026 | Stock Option Exercise - Options Granted March 06, 2023 Cash | 125K | — |
3/7/2025 | Restricted Stock Units vesting - granted March 7, 2025 Compensatory payment | 13.01K | — |
3/6/2025 | Restricted Stock Units vesting - granted March 6, 2025 Compensatory payment | 10.99K | — |
| Total | 209K | ||
Completed
Units to sell
21K
Market value
$415.6K
Units to sell
21K
Market value
$336.0K
Planned — Approximate Date
Units to sell
84K
Market value
$1.35M
Units to sell
125K
Market value
$2.01M
Units
251K
Value
$4.11M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/15/2025 | 21K | $415.6K | — | Completed |
11/19/2025 | 21K | $336.0K | — | Completed |
| Planned — Approximate Date | ||||
2/17/2026 | 84K | $1.35M | NASDAQ | Planned |
2/17/2026 | 125K | $2.01M | NASDAQ | Planned |
| Total | 251K | $4.11M | ||